Pharma Manufacturing Shift Accommodates Cell and Gene Therapy
Pharma Manufacturing Shift AccommodatesCell and Gene Therapy Manufacturing in pharmaceuticals must evolve to accommodate increased research and usage of cell gene therapy. This can be done via acquisitions and mergers or through the expansion of manufacturing capabilities within a single company. Cell and gene therapy use genetic material, or DNA, to manipulate a patient's cells [...]